HANDBOOK OF TOXICOLOGY-ANTIBIOTICS. W.B.SAUNDERS CO., PHILADELPHIA.

Title	HANDBOOK OF TOXICOLOGY-ANTIBIOTICS. W.B.SAUNDERS CO., PHILADELPHIA.
Authors	SPECTOR,WS:
Year	1957
Volume	2
Issue

Streptomyces species (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMYCOBACTERIAL ACTIVITY	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	THIOSTREPTON	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	THIOSTREPTON	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	THIOSTREPTON	INACTIVE

Bacillus brevis (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMYCOBACTERIAL ACTIVITY	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BREVIN	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BREVIN	ACTIVE

Streptomyces hawaiiensis (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BRYAMYCIN	ACTIVE
2	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BRYAMYCIN	INACTIVE
3	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BRYAMYCIN	.
4	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BRYAMYCIN	.
5	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BRYAMYCIN	.

Streptomyces cinnamomeus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VIVO	CINNAMYCIN	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CINNAMYCIN	.
3	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CINNAMYCIN	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CINNAMYCIN	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CINNAMYCIN	ACTIVE

Bacterium antimyceticum (BACTERIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HEMOLYTIC ACTIVITY	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITRO	COMIRIN	STRONG ACTIVITY
2	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	COMIRIN	ACTIVE
3	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	COMIRIN	ACTIVE
4	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	COMIRIN	ACTIVE
5	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	COMIRIN	ACTIVE

Bacillus circulans (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMITOTIC ACTIVITY(PLANT CELLS)	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	CIRCULIN	ACTIVE
2	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CIRCULIN	.
3	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CIRCULIN	.
4	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE
5	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE
6	ANTITRICHOMONAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE

Bacillus laterosporus (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LATEROSPORIN A	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LATEROSPORIN A	ACTIVE
3	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LATEROSPORIN A	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LATEROSPORIN A	ACTIVE

Streptomyces subtropicus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ALBOMYCIN	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ALBOMYCIN	ACTIVE

Bacillus alvei (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMYCOBACTERIAL ACTIVITY	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ALVEIN	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ALVEIN	ACTIVE
3	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALVEIN	ACTIVE

Streptomyces canus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMPHOMYCIN	ACTIVE
2	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMPHOMYCIN	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AMPHOMYCIN	INACTIVE
4	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	AMPHOMYCIN	.
5	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	AMPHOMYCIN	.
6	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	AMPHOMYCIN	.

Bacillus subtilis (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VIVO	BACILLOMYCIN	.
2	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BACILLOMYCIN	ACTIVE
3	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLOMYCIN B	ACTIVE
4	Not specified	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE	BACILLOMYCIN C	None
5	ANTIBACTERIAL ACTIVITY	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FLUVOMYCIN	ACTIVE
6	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FLUVOMYCIN	ACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FLUVOMYCIN	ACTIVE
8	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FLUVOMYCIN	ACTIVE
9	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	FLUVOMYCIN	.
10	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	FLUVOMYCIN	.
11	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	FLUVOMYCIN	.
12	TOXICITY ASSESSMENT(QUANTITATIVE)	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VIVO	SUBTILIN	.
13	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	SUBTILIN	.
14	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	ACTIVE
15	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	ACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	ACTIVE
17	ANTIAMEBIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	ACTIVE
18	ANTITRYPANOSOMAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	WEAK ACTIVITY
19	ANTITRYPANOSOMAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	ACTIVE
20	ANTITRYPANOSOMAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	INACTIVE
21	ANTITRYPANOSOMAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SUBTILIN	INACTIVE
22	ANTIBACTERIAL ACTIVITY	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOXIMYCIN	ACTIVE
23	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOXIMYCIN	ACTIVE

Serratia marcescens (ENTEROBACTERIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VIVO	MARCESIN	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	MARCESIN	.
3	NECROTIC EFFECT	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	MARCESIN	ACTIVE
4	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCESIN	ACTIVE
5	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MARCESIN	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MARCESIN	ACTIVE

Streptococcus cremoris (STREPTOCOCCACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VIVO	NISIN	.
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	NISIN	WEAK ACTIVITY
3	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	NISIN	ACTIVE

Bacillus krzemieniewski (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	UV SPECTRUM GIVEN FORISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN VIVO	CIRCULIN	.
2	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRCULIN	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE
5	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE
6	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CIRCULIN	ACTIVE

Citation 46931

Citation Details

Summary

Organisms and Their Experiments (14)

Streptomyces species (STREPTOMYCETACEAE)

Bacillus brevis (BACILLACEAE)

Streptomyces hawaiiensis (STREPTOMYCETACEAE)

Streptomyces cinnamomeus (STREPTOMYCETACEAE)

Bacterium antimyceticum (BACTERIACEAE)

Bacillus circulans (BACILLACEAE)

Bacillus laterosporus (BACILLACEAE)

Streptomyces subtropicus (STREPTOMYCETACEAE)

Bacillus alvei (BACILLACEAE)

Streptomyces canus (STREPTOMYCETACEAE)

Bacillus subtilis (BACILLACEAE)

Serratia marcescens (ENTEROBACTERIACEAE)

Streptococcus cremoris (STREPTOCOCCACEAE)

Bacillus krzemieniewski (BACILLACEAE)

Show SPARQL Queries (1)

Query 1